This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
200+ treatment naive subjects are enrolled in the current Phase 2 trial - Prove 1. Early starters are around week 13 of what will be 12, 24, or 48 weeks for each arm of the trial respectively. VL information may start to become available one all subjects are unblinded around week 20.
A similar large study for non responders is in the works for early 2007, although I suspect this will be somewhat dependent on early results from the Prove 1 trial.
VX950 was recently granted FDA Fast Track status, which should speed up the approval process IF the trials confirm good efficacy and no safety issues.
Most of us remain with regular old combo.
Ron
PLN, PrettyDamnScared, mremeet, LabRat and TravelMom are all in the trial, although mremeet stopped VX dosing early due to a nasty rash issue. PLN has rash problems as well, but said today that she will finish her final week of VX dosing.
There may be others here who are in the trial , but they are the names I know for sure.
FWIW, your skin condition is definitely the toughest side I've read about. You are a man of steel to hang in through all that!
Post was thread "Skin Part 2", post C18, about 13 threads down from here.
http://www.medhelp.org/forums/Hepatitis/messages/43220.html
got you covered on the other thread. Sorry I missed your post earlier!
copyman,
I've got a mild case of what look very much like the usual soc sx, including intense itching, a simple small dot rash on chest, arms and upper back, mild insomnia, and borderline anemia. Ambien deals with the sleep when required, a gallon a water a day seems to calm the itch a little. No dose reduction so long as the HGB bounces along above 10.0 [its 10.5 at last test].
I flat out don't know if I'm on VX or placebo, but my ALT and AST levels dropped from 124 & 79 respectively to normal range in less than 8 days, and have remained in the 20's since then. I see that as a good sign, but nothing will be certain until we are unblinded and get to see the VL numbers for the entire trial period. That will be a great day, I suspect!
"...There are ten subjects in my group. Only one has dropped out so far, and that was due to extreme and unmanageable psych sides. None have serious rash issues..."
Hopefully this will put in perspective some recent posts on a rash problem reported by another member. I'd hate to see people discouraged, scared away, or given irresponsible advice based on a single treatment experience.
All the best moving forward, and that swift drop in LFT's certainly is encouraging.
Be well,
Jim
This is a cross-post from Skin 2. Adding it here as another data point:
PLN said "There are 7 people in my [VX950] study only one had to droped out, due to the fact she could not handle the meds no rash."
The evidence is mounting. While we all must feel empathy for what is obviously an acute rash that MRE is suffering, there seems to be little clear evidence to suggest that his rash is due to VX950 specifically. At very least, we would expect to see similar rash issues in other groups in the study. We now know of two groups that have experienced no such issues.
-----------------------------------------------------------
This is really the important point. I'd just ammend that to say that even if MRE's rash was caused by VX-950, such a severe reaction is uncommon with the rest of the study participants that you, PLN and LabRat have reported on. Maybe there was something in the placebo pill that MRE was allegic too :) Just kidding, MRE and no hard feelings at all. I posted to you more in the skin 2 thread below.
-- Jim